Sunesis Pharmaceuticals (SNSS) Soars: Stock Adds 8% in Session

Zacks

Sunesis Pharmaceuticals, Inc. (SNSS) was a big mover last session, as its shares rose roughly 8% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company, as the stock is now up over 16% in the past one-month timeframe.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Sunesis Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Gilead Sciences Inc. (GILD), ANI Pharmaceuticals, Inc. (ANIP) and Illumina Inc. (ILMN). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




SUNESIS PHARMACEUTICALS INC NEW (SNSS): Free Stock Analysis Report

GILEAD SCIENCES INC (GILD): Free Stock Analysis Report

ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report


Zacks Investment Research

View Comments (0)